Difference between revisions of "Team:GreatBay SCIE"

 
(19 intermediate revisions by 3 users not shown)
Line 19: Line 19:
  
 
<a href="https://2021.igem.org/Team:GreatBay_SCIE" style="padding-right:0px">
 
<a href="https://2021.igem.org/Team:GreatBay_SCIE" style="padding-right:0px">
<img class="plogo" id="project_logo" src="https://static.igem.org/mediawiki/2021/6/6a/T--GreatBay_SCIE--Project_Logo.png" alt="logo" height="46"
+
<img class="plogo" id="project_logo" src="https://static.igem.org/mediawiki/2021/6/6a/T--GreatBay_SCIE--Project_Logo.png" alt="logo" height="46" style="position:absolute; margin-left:50px; margin-top:10px; left:0px;">
height:"46"; style="position:absolute; margin-left:50px; margin-top:10px;">
+
<img class="tlogo" id="team_logo" src="https://static.igem.org/mediawiki/2021/0/06/T--GreatBay_SCIE--Team_Logo.png" alt="logo" height="46" style="position:absolute; left:0; margin-top:13px!important; left:0px;">
<img class="tlogo" id="team_logo" src="https://static.igem.org/mediawiki/2021/0/06/T--GreatBay_SCIE--Team_Logo.png" alt="logo" height="46" style="position:absolute; left:0; margin-top:13px!important;">
+
 
</a>
 
</a>
 
+
<ul style="margin-left: -11px">   
<ul style="margin=left:-4px">   
+
 
         <li>
 
         <li>
 
             <a href="https://2021.igem.org/Team:GreatBay_SCIE">Home</a>
 
             <a href="https://2021.igem.org/Team:GreatBay_SCIE">Home</a>
Line 68: Line 66:
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Optimum_Aptamer_Concentration" >Optimum Liposome-Aptamer Ratio</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Optimum_Aptamer_Concentration" >Optimum Liposome-Aptamer Ratio</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Drug_Loading">Drug Loading</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Drug_Loading">Drug Loading</a></li>
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Dissociation_constant">Dissociation_constant</a></li>
+
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Dissociation_constant">Dissociation Constant</a></li>
 
  <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/3D_Model">3D Models</a></li>
 
  <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/3D_Model">3D Models</a></li>
  
Line 95: Line 93:
 
<br>
 
<br>
 
<br>
 
<br>
<div class="title" style="align:center; font-family: Kumbh Sans;">Our Solution</div>
+
<div class="title" style="align:center; font-family: Kumbh Sans;">| &nbsp;&nbsp; Our Solution &nbsp;&nbsp; |</div>
 
</center>
 
</center>
  
Line 105: Line 103:
 
<br>
 
<br>
 
<br>
 
<br>
<br><br>
 
 
<br>
 
<br>
<br><br>
 
 
<br>
 
<br>
<br><br>
 
 
<br>
 
<br>
<br><br>
 
 
<br>
 
<br>
<br><br>
 
<br>
 
<br>
 
<br>
 
<br>
 
<br><br>
 
<br>
 
<br><br>
 
<br>
 
<br><br>
 
<br>
 
<br><br>
 
<br>
 
<br><br>
 
 
<br>
 
<br>
 
<br>
 
<br>
 +
<!--
 +
<img id="header3" src="https://static.igem.org/mediawiki/2021/5/53/T--GreatBay_SCIE--Main_Transition_1.png" class="bg_image" style="z-index:8; width:100%;"></img>
 
<img id="header3" src="https://static.igem.org/mediawiki/2021/a/ac/T--GreatBay_SCIE--Head3.png" class="bg_image" style="z-index:8; width:100%;"></img>
 
<img id="header3" src="https://static.igem.org/mediawiki/2021/a/ac/T--GreatBay_SCIE--Head3.png" class="bg_image" style="z-index:8; width:100%;"></img>
 
+
-->
<div class="title" style="font-family: Kumbh Sans; font-size:500% !important; text-align:center; font-weight: 700; color: #19232F; margin: 50px;">Check Out Our Promotion Video! ↓</div>
+
<img id="header3" src="https://static.igem.org/mediawiki/2021/4/47/T--GreatBay_SCIE--Main_Transition_full.png" class="bg_image" style="z-index:8; width:100%;">
 +
<div class="title" style="font-family: Kumbh Sans; font-size:500% !important; text-align:center; font-weight: 700; color: #19232F; margin-top: 0px;margin: 50px;">Check Out Our Promotion Video! ↓</div>
  
 
<center>
 
<center>
Line 177: Line 160:
 
           <a href="https://2021.igem.org/Team:GreatBay_SCIE/Model"><h2>MODEL</h2></a>
 
           <a href="https://2021.igem.org/Team:GreatBay_SCIE/Model"><h2>MODEL</h2></a>
 
           <p>
 
           <p>
           We design two specific models which collect datas from both our experiments and published theses to calculate and predict the best conditions for our system.
+
           We design two specific models which collect datas from both of our experiments and publish theses to calculate and predict the best conditions for our system.
 
           </p>
 
           </p>
 
</li>
 
</li>
Line 184: Line 167:
 
           <a href="https://2021.igem.org/Team:GreatBay_SCIE/Human_Practices"><h2>HP</h2></a>
 
           <a href="https://2021.igem.org/Team:GreatBay_SCIE/Human_Practices"><h2>HP</h2></a>
 
           <p>
 
           <p>
           Through contacting professors, doctors, and public service organizations, we not only receive useful advice for our methods and experiments but also learn the feelings and needs of breast cancer patients, which urges us to pay attention to those sufferers and the social problems behind.
+
           Through contacting professors, doctors, and public service organizations, we not only receive useful advice for our methods and experiments but also understand patients' feelings and know their needs.
 
           </p>
 
           </p>
 
</li>
 
</li>
 
</ul>
 
</ul>
 +
 +
<br>
 +
 +
<br>
 +
<br>
 +
<br>
 +
 
<img id="head" src="https://static.igem.org/mediawiki/2021/d/da/T--GreatBay_SCIE--Bottom_Banner.png" class="bg_image" style="z-index:9; width:100%;"></img>
 
<img id="head" src="https://static.igem.org/mediawiki/2021/d/da/T--GreatBay_SCIE--Bottom_Banner.png" class="bg_image" style="z-index:9; width:100%;"></img>
 
</body>
 
</body>
 
</html>
 
</html>

Latest revision as of 15:22, 21 October 2021






|    Our Solution    |










Check Out Our Promotion Video! ↓
  • TEAM

    GreatBay_SCIE consists of 15 enthusiastic and imaginative students, who aim to apply synthetic biology in real life.

  • PROJECT

    We design an improved ligand-nanoparticle system which utilizes pH-sensitive aptamer to improve specificity on targeting HER2 proteins.

  • LAB

    Our lab is made up of three main parts: aptamer experiment, nanoparticles manufacturing & modification, and cell cultivation & experiments, of which results verified the availability and prospect of our system.

  • MODEL

    We design two specific models which collect datas from both of our experiments and publish theses to calculate and predict the best conditions for our system.

  • HP

    Through contacting professors, doctors, and public service organizations, we not only receive useful advice for our methods and experiments but also understand patients' feelings and know their needs.